Tadashi Matsuura
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Clinical-stage human anti-transferrin receptor antibodies suppress colorectal cancer metastasis.
Journal: Signal transduction and targeted therapy
Published: October 21, 2025
Impact of residual kidney function on hemodynamic changes during induction of general anesthesia in hemodialysis patients: a retrospective observational study.
Journal: Journal of anesthesia
Published: October 05, 2025
A potential mechanism and strategy for accelerating recovery of neurocognitive function after general anaesthesia through store-operated Orai1 channels.
Journal: British journal of pharmacology
Published: June 10, 2025
Anti-transferrin receptor 1 antibody reduces angiotensin II-induced vascular remodeling.
Journal: Journal of molecular and cellular cardiology
Published: November 16, 2024
Deterioration and Manifestation of Cerebral Fat Embolism Triggered by Bone Reaming During Femur Fracture Surgery: A Case Report.
Journal: Clinical case reports
Published: November 11, 2024
Anti-transferrin receptor antibody (JST-TFR09/PPMX-T003) induces ferroptosis in adult T-cell leukemia/lymphoma (ATLL) cells.
Journal: Biochemical and biophysical research communications
Published: October 16, 2024
Right Ventricular Dysfunction in Cardiac Anesthesia: Perioperative Assessment and Underlying Mechanisms.
Journal: Reviews in cardiovascular medicine
Published: August 27, 2024
Possible role of QRS duration in the right ventricle as a perioperative monitoring parameter for right ventricular function: a prospective cohort analysis in robotic mitral valve surgery.
Journal: Frontiers in cardiovascular medicine
Published: April 16, 2024
Phase 1 Clinical Trial of PPMX-T003, a Novel Human Monoclonal Antibody Specific for Transferrin Receptor 1, to Evaluate Its Safety, Pharmacokinetics, and Pharmacodynamics.
Journal: Clinical pharmacology in drug development
Published: October 17, 2022
The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin-transferrin receptor 1 axis.
Journal: Blood
Published: October 03, 2022
Last Updated: 09/26/2026